日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bombina maxima Maximins 11/H1 CSB-YP691320BIA
CSB-EP691320BIA
CSB-BP691320BIA
CSB-MP691320BIA
CSB-EP691320BIA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombina maxima Maximins 8/H7 CSB-YP691321BIA
CSB-EP691321BIA
CSB-BP691321BIA
CSB-MP691321BIA
CSB-EP691321BIA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombina maxima Maximins 3/H9 type 1 CSB-YP691322BIA
CSB-EP691322BIA
CSB-BP691322BIA
CSB-MP691322BIA
CSB-EP691322BIA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bombina maxima Maximins 3/H3 type 3 CSB-YP691323BIA
CSB-EP691323BIA
CSB-BP691323BIA
CSB-MP691323BIA
CSB-EP691323BIA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Probable G-protein coupled receptor 113 (Gpr113), partial CSB-YP691324MO
CSB-EP691324MO
CSB-BP691324MO
CSB-MP691324MO
CSB-EP691324MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1614 (MJ1614) CSB-YP691325MRU
CSB-EP691325MRU
CSB-BP691325MRU
CSB-MP691325MRU
CSB-EP691325MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1625 (MJ1625), partial CSB-YP691326MRU
CSB-EP691326MRU
CSB-BP691326MRU
CSB-MP691326MRU
CSB-EP691326MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1633 (MJ1633) CSB-YP691327MRU
CSB-EP691327MRU
CSB-BP691327MRU
CSB-MP691327MRU
CSB-EP691327MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii tRNA (pseudouridine (54)-N (1))-methyltransferase (trmY) CSB-YP691328MRU
CSB-EP691328MRU
CSB-BP691328MRU
CSB-MP691328MRU
CSB-EP691328MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Phosphoribosylformylglycinamidine synthase 1 (purQ) CSB-YP691329MRU
CSB-EP691329MRU
CSB-BP691329MRU
CSB-MP691329MRU
CSB-EP691329MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1656 (MJ1656) CSB-YP691330MRU
CSB-EP691330MRU
CSB-BP691330MRU
CSB-MP691330MRU
CSB-EP691330MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Probable molybdenum cofactor guanylyltransferase (mobA) CSB-YP691331MRU
CSB-EP691331MRU
CSB-BP691331MRU
CSB-MP691331MRU
CSB-EP691331MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1667 (MJ1667) CSB-YP691332MRU
CSB-EP691332MRU
CSB-BP691332MRU
CSB-MP691332MRU
CSB-EP691332MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanocaldococcus jannaschii Uncharacterized protein MJ1680 (MJ1680) CSB-YP691333MRU
CSB-EP691333MRU
CSB-BP691333MRU
CSB-MP691333MRU
CSB-EP691333MRU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus necator Pyruvate dehydrogenase E1 component (pdhA), partial CSB-YP691334DZQ
CSB-EP691334DZQ
CSB-BP691334DZQ
CSB-MP691334DZQ
CSB-EP691334DZQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cupriavidus necator Nitrous-oxide reductase (nosZ), partial CSB-YP691335DZQ
CSB-EP691335DZQ
CSB-BP691335DZQ
CSB-MP691335DZQ
CSB-EP691335DZQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arcanobacterium haemolyticum Phospholipase D (pld) CSB-YP691336DOB
CSB-EP691336DOB
CSB-BP691336DOB
CSB-MP691336DOB
CSB-EP691336DOB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaerocellum thermophilum DNA polymerase I (polA), partial CSB-YP691337BYP
CSB-EP691337BYP
CSB-BP691337BYP
CSB-MP691337BYP
CSB-EP691337BYP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum 10 kDa chaperonin (groS) CSB-YP691338BXE
CSB-EP691338BXE
CSB-BP691338BXE
CSB-MP691338BXE
CSB-EP691338BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Microcebus sambiranensis NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP691339MDAX1
CSB-EP691339MDAX1
CSB-BP691339MDAX1
CSB-MP691339MDAX1
CSB-EP691339MDAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×